Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide-Dexamethasone for Multiple Myeloma
NCT00038090Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2000
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of thalidomide in multiple myeloma (MM), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Response Rate. Started Jun 2000; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00038090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038090.